1. Home
  2. DGHI vs TLSA Comparison

DGHI vs TLSA Comparison

Compare DGHI & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGHI
  • TLSA
  • Stock Information
  • Founded
  • DGHI 2017
  • TLSA 2013
  • Country
  • DGHI United States
  • TLSA United Kingdom
  • Employees
  • DGHI N/A
  • TLSA N/A
  • Industry
  • DGHI Finance: Consumer Services
  • TLSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • DGHI Finance
  • TLSA Health Care
  • Exchange
  • DGHI Nasdaq
  • TLSA Nasdaq
  • Market Cap
  • DGHI 90.1M
  • TLSA 87.8M
  • IPO Year
  • DGHI N/A
  • TLSA 2000
  • Fundamental
  • Price
  • DGHI $2.58
  • TLSA $0.88
  • Analyst Decision
  • DGHI Strong Buy
  • TLSA
  • Analyst Count
  • DGHI 1
  • TLSA 0
  • Target Price
  • DGHI $2.50
  • TLSA N/A
  • AVG Volume (30 Days)
  • DGHI 995.6K
  • TLSA 1.1M
  • Earning Date
  • DGHI 04-02-2025
  • TLSA 02-25-2025
  • Dividend Yield
  • DGHI N/A
  • TLSA N/A
  • EPS Growth
  • DGHI N/A
  • TLSA N/A
  • EPS
  • DGHI N/A
  • TLSA N/A
  • Revenue
  • DGHI $42,146,057.00
  • TLSA N/A
  • Revenue This Year
  • DGHI N/A
  • TLSA N/A
  • Revenue Next Year
  • DGHI N/A
  • TLSA N/A
  • P/E Ratio
  • DGHI N/A
  • TLSA N/A
  • Revenue Growth
  • DGHI 100.56
  • TLSA N/A
  • 52 Week Low
  • DGHI $0.84
  • TLSA $0.41
  • 52 Week High
  • DGHI $3.77
  • TLSA $1.74
  • Technical
  • Relative Strength Index (RSI)
  • DGHI 47.47
  • TLSA 64.21
  • Support Level
  • DGHI $2.81
  • TLSA $0.65
  • Resistance Level
  • DGHI $3.48
  • TLSA $0.70
  • Average True Range (ATR)
  • DGHI 0.43
  • TLSA 0.06
  • MACD
  • DGHI -0.09
  • TLSA 0.02
  • Stochastic Oscillator
  • DGHI 2.34
  • TLSA 98.77

About DGHI Digihost Technology Inc. Common Subordinate Voting Shares

Digihost Technology Inc is a blockchain company focused on Bitcoin mining. The company's mining facility is located in Buffalo, New York, and is equipped with an 18.7 MVA 115,000-kilovolt ampere outdoor substation with an option to increase the power output to 42MVA.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: